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Highlights 
• Diet induced obese rat models of OAGB, SADS, RYGB, and SG are suitable preclinical models. 
Weight loss and improved glucose dynamics are similar to those in the clinic. 
• OAGB results in metabolic improvements that met or exceed RYGB. 
• Each surgical procedure results in a specific metabolic signature – including differential changes 
in food intake, insulin, GLP-1 response, iron regulation, and fecal microbiota. 
Abstract 
Background 
One-anastomosis gastric bypass (OAGB) and single-anastomosis duodenal switch (SADS) have become 
increasingly popular weight loss strategies. However, data directly comparing the effectiveness of these 
procedures with Roux-en-Y gastric bypass (RYGB) and vertical sleeve gastrectomy (SG) are limited. 
Objectives 
To examine the metabolic outcomes of OAGB, SADS, RYGB, and SG in a controlled rodent model. 
Setting 
Academic research laboratory, United States. 
Methods 
Surgeries were performed in diet-induced obese Long-Evans rats, and metabolic outcomes were 
monitored before and for 15 weeks after surgery. 
Results 
All bariatric procedures induced weight loss compared with sham that lasted throughout the course of 
the study. The highest percent fat loss occurred after OAGB and RYGB. All bariatric procedures had 
improved glucose dynamics associated with an increase in insulin (notably OAGB and SADS) and/or 
glucagon-like protein-1 secretion. Circulating cholesterol was reduced in OAGB, SG, and RYGB. OAGB 
and SG additionally decreased circulating triglycerides. Liver triglycerides were most profoundly reduced 
after OAGB and RYGB. Circulating iron levels were decreased in all surgical groups, associated with a 
decreased hematocrit value and increased reticulocyte count. The fecal microbiome communities of 
OAGB, SADS, and RYGB were significantly altered; however, SG exhibited no change in microbiome 
diversity or composition. 
Conclusions 
These data support the use of the rat for modeling bariatric surgical procedures and highlight the ability 
of the OAGB to meet or exceed the metabolic improvements of RYGB. These data point to the likelihood 
that each surgery accomplishes metabolic improvements through both overlapping and distinct 
mechanisms and warrants further research. 
Keywords 
One-anastomosis gastric bypass; Single-anastomosis duodenal switch; Roux-en-Y gastric bypass; Sleeve 
gastrectomy; Rodent; Animal model; Glucose regulation 
 
Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) are the most commonly performed 
bariatric surgical procedures1 and result in significant and sustained weight loss accompanied by 
dramatic changes in glucose metabolism.2,3 However, surgeons continue to explore other procedures 
that may carry advantages in terms of surgical approach or metabolic improvements. Among these 
procedures are the one-anastomosis gastric bypass (OAGB), also known as the mini bypass or the omega 
loop gastric bypass, and the single-anastomosis duodenal switch (SADS), both of which produce 
significant improvements in weight and glucose homeostasis.4,5 
Surgeons drawing observations from patients have dominated the development of these bariatric 
procedures. Nonetheless, the utilization of animal models is an important step in pinpointing the 
surgical effects on metabolism independent of genetic background, diet adherence, and environmental 
conditions. By allowing investigators to test a wide range of hypotheses while limiting variability 
compared with the human population, animal models enable the identification of mechanistic 
hypotheses to explain the potent metabolic effects of bariatric surgery. Of note, the use of animal 
models in this study confers the following 2 important benefits over clinical studies: (1) when possible, 
we standardize gut manipulations to draw meaningful comparisons on how specific changes to gut 
physiology impact metabolism; and (2) as animal models do not follow clinician advice on diet and/or 
exercise, any observed outcomes are due entirely to the surgical procedure and its effect on the brain 
and overall physiology. An important validity measure of these animal models depends on the similarity 
in postsurgical responses compared with the patient population at the level of weight maintenance and 
metabolic outcome. 
Indeed, the mechanisms by which bariatric surgical procedures result in weight loss and metabolic 
improvements are still not completely understood. A number of hypotheses have been forwarded to 
explain these metabolic improvements, including the involvement of glucose-regulating gut hormones, 
such as glucagon-like protein-1 (GLP-1),6,7 bile acids,8,9 and alterations in the microbiome.10,11 By 
comparing different bariatric surgical procedures in obese rats, we can systemically investigate the 
physiologic components correlated with metabolic success and how they relate to specific physical 
changes of the surgery. Moreover, we can identify what surgical intervention may be more effective for 
a specific metabolic outcome in a controlled, nonvariable setting. Here, we present evidence that our 
rodent procedure similar to OAGB meets or exceeds the metabolic improvements of the comparative 
gold standard bariatric surgical procedure, the RYGB. Moreover, each bariatric surgical procedure leads 
to differential effects on metabolism, and when viewed in light of the surgical approach, suggests that a 
combination of overlapping and distinct mechanisms may contribute to the general success of bariatric 
surgery. 
Methods 
Animals 
Male Long-Evans rats (Envigo, Indianapolis, IN, USA) were maintained on a high-fat diet with butter fat 
(40% fat, 4.54 kcal/g; D03082706 Research Diets, New Brunswick, NJ, USA) to induce obesity before 
bariatric surgery. Before surgery, all rats received baseline measurement of weight and body 
composition. After surgery, rats were maintained on the same high-fat diet. Weight, food intake, and 
body composition were measured periodically over 15 weeks. The number of animals per group that 
survived until the end of the study were as follows: sham (7/9), RYGB (7/13), OAGB (6/13), SG (12/13), 
and SADS (9/13). Rats were excluded from analysis for failure to recover from the surgery or for 
exhibiting signs of intestinal obstruction or infection. Rats were individually housed in temperature-
controlled rooms with a 12:12-hour light cycle. All studies were approved by and performed according 
to the guidelines of the Institutional Animal Care and Use Committee of the University of Michigan. 
Surgery 
After induction of isoflurane anesthesia, animals received buprenorphine hydrochloride (.03 mg/kg), 
meloxicam (.5 mg/kg), gentamicin (8 mg/kg), and 10 mL isotonic saline, all by subcutaneous injection. All 
surgeries began with a midline abdominal skin incision, followed by an incision in the underlying muscle 
wall. All anastomoses were performed with 8-0 Prolene sutures (Ethicon, Somerville, NJ, USA) and 
abdominal closures were performed in 2 layers with 4-0 Vicryl Rapide sutures (Ethicon). Postoperatively, 
animals received a liquid diet (Osmolite1 Cal, Abbott Nutrition, Abbott Laboratories; Columbus, OH, 
USA) for 4 days before being returned to the previously described high-fat diet. All animals received 
subcutaneous injection of buprenorphine hydrochloride twice daily and meloxicam and gentamicin once 
daily for 3 days. 
Sham surgery 
The stomach was exposed, gentle pressure applied with forceps, and the stomach was covered with a 
gauze pad soaked in sterile saline. The stomach was returned to the body cavity and the incision closed. 
Roux-en-Y gastric bypass 
The stomach and the intestines were exposed and draped on a gauze pad soaked in sterile saline. A 
triangular stomach pouch of reduced volume was created via 2 intersecting cuts using an endoscopic 
stapler (Endopath ETS-Flex 35 mm Endoscopic Articulating Linear Cutter; Ethicon Endo-Surgery Inc., 
Cincinnati, OH, USA) to separate the pouch from the remnant stomach. The jejunum was transected 30 
cm distal to the ligament of Treitz, and a gastrotomy incision was made in the stomach pouch. The 
transected end of the distal portion of the jejunum was anastomosed to the gastrotomy (forming the 
Roux limb) with interrupted sutures. The remaining transected end of the proximal portion of the 
intestine was then anastomosed with interrupted sutures to the Roux limb as an end-to-side jejuno-
jejunostomy at 10 cm from the gastrojejunostomy. 
One-anastomosis gastric bypass 
The stomach and the intestines were exposed and draped on a gauze pad soaked in sterile saline. A 
stomach pouch of reduced volume was created as described for RYGB. The jejunum at 30 cm from the 
ligament of Treitz was brought up to contact the stomach pouch, and incisions of comparable length 
were made in both. The jejunum was anastomosed to the stomach pouch with interrupted sutures. 
Note, we have selected a limb length similar to our RYGB procedure to make meaningful comparisons 
about the effect of a single anastomosis on metabolic outcomes. Thus, this method deviates from 
clinical OAGB in that OAGB procedures traditionally have a longer limb length than that of RYGB 
procedures. 
Sleeve gastrectomy 
The stomach was exposed and transected to form a sleeve using an endoscopic stapler (ETS-Flex 35; 
Ethicon). Approximately 70% of the rat stomach (by weight) was removed, including the majority of the 
fundus and about 50% of the pyloric antrum. 
Single-anastomosis duodenal switch 
The stomach was exposed and covered with a gauze pad soaked in sterile saline. The duodenum was 
identified and transected proximally to where the common bile duct enters; the free end of the distal 
duodenum was sutured. The gauze was removed from the stomach, which was transected to form a 
sleeve as described for SG. The jejunum (at 30 cm from the ligament of Treitz) was mobilized to contact 
the proximal duodenal free end and an incision was made in the antimesenteric side of the former to 
match its length to the duodenal diameter. The jejunum was connected to the proximal duodenal 
segment by side-to-end anastomosis with interrupted sutures. As with the OAGB procedure, we have 
selected a limb length similar to our RYGB procedure to make meaningful comparisons about the effect 
of intestinal rerouting in the context of a reduced stomach size on metabolic outcomes. Thus, this 
method deviates from clinical SADS in that SADS procedures traditionally have a much longer limb 
length than that of RYGB procedures. 
Metabolic outcome methods 
Detailed methods on metabolic outcome measures, including body composition, mixed-meal glucose 
tolerance tests, total GLP-1 measures, lipid analysis, iron regulation, and fecal microbiome can be found 
in supplementary methods. 
Statistical analysis 
Statistical analysis was performed using GraphPad Prism (GraphPad, La Jolla, USA). Unless otherwise 
specified, we used one-way analysis of variance and Tukey post hoc tests where necessary to determine 
significant differences between groups. We used a repeated-measures analysis of variance for analysis 
of weight and food intake over time with a Bonferroni's multiple comparison test when a significant 
interaction effect was found. All statistical analysis used a 2-tailed design and results were considered 
significant when P < .05. 
Results 
Surgical effect on body mass and body composition 
In comparison to the control sham surgery, all bariatric surgical groups lost weight and maintained a 
lower weight for the duration of the 15-week study (106 d). The RYGB and OAGB groups lost the most 
weight, whereas SG and SADS groups lost an intermediate amount of weight (Figs. 1A, 1B). Post hoc 
analysis on total weight loss revealed that all groups lost more weight than sham (P < .001), and RYGB 
lost significantly more weight than SG (P < .05). 
 
Fig. 1. Surgical effect on body mass and body composition. (A) Absolute weight changes (in g) after surgery. *All 
groups differ from sham; †one-anastomosis gastric bypass, Roux-en-Y gastric bypass, and single-anastomosis 
duodenal switch differ from sham. (B) Percent change from baseline weight after surgery. *All groups differ from 
sham; †one-anastomosis gastric bypass, Roux-en-Y gastric bypass, and single-anastomosis duodenal switch differ 
from sham. (C) Absolute change in fat mass 15 weeks postsurgery. ****Significant difference from Sham, P 
< .0001. (D) Absolute change in lean mass 15 weeks postsurgery. 
Body fat composition was similarly altered 15 weeks after surgery, with all groups losing a significant 
amount of fat mass compared with sham (Fig. 1C). The largest amount of fat loss occurred after OAGB 
and RYGB, with SADS and SG exhibiting an intermediate amount of fat loss (Fig. 1C). Post hoc analysis 
revealed that OAGB lost significantly more fat mass than SG (P < .001) and SADS (P < .05). RYGB lost 
significantly more fat mass than SG (P < .01). 
Surgery did not affect change in lean mass (Fig. 1D), and there were no significant differences in baseline 
fat or lean mass (Supplemental Fig. 1). 
Surgical effect on food intake 
Rats were maintained on a high-fat diet before and after surgery. Cumulative food intake, as measured 
from surgical recovery to 14 weeks (98 d) postsurgery, was reduced after the OAGB and SG compared 
with sham (Fig. 2A). Cumulative food intake was not reduced in RYGB or SADS compared with sham-
operated animals (Fig. 2A). All surgical groups exhibited a transient decrease in food intake 2 weeks (SG, 
P < .001; OAGB, RYGB, SADS, P < .0001) and 3 weeks (SADS, P < .01; SG, P < .001; OAGB, RYGB, P < .0001) 
after surgery compared with sham-operated controls (Fig. 2B). Notably, the OAGB and SG groups, which 
also had significant reductions in cumulative intake, exhibited longer transient reductions in food intake 
of approximately 6 weeks (42 d) in duration. 
 
Fig. 2. Surgical effect on food intake. (A) Cumulative caloric intake from surgical recovery to 14 weeks postsurgery. 
**Significant difference from sham, P < .01 (B) Weekly caloric intakes of each surgical group; *All groups differ 
from sham; †one-anastomosis gastric bypass and sleeve gastrectomy differ from sham. 
Surgical effect on glucose regulation 
Fasting glucose levels were only decreased in the SG compared with sham controls (Fig. 3A). In response 
to an oral mixed-meal glucose tolerance test, all surgical groups had improved glucose clearance and 
lower glucose levels at 30, 45, and 60 minutes after the oral load compared with sham-operated 
controls (Fig. 3B). The rise in blood glucose (e.g., the difference between the 15- min time point and the 
baseline) was significantly greater in OAGB (P < .01), RYGB (P < .05), and SADS (P < .05) compared with 
the glucose rise experienced by sham-operated controls (Fig. 3B). 
 
Fig. 3. Surgical effect on glucose regulation. (A) Fasting blood glucose levels. *Significant difference from sham, P 
< .05. (B) Glucose response to an oral mixed-meal tolerance test. *Significant difference from sham, P < .05. (C) 
Baseline/fasting plasma insulin levels and plasma insulin 15 minutes after an oral mixed meal. *Significant 
difference from sham at same time point, P < .05, **P < .01, ****P < .0001. (D) Total glucagon-like protein-1 
response to an oral mixed-meal tolerance test. *All groups significant difference from sham, P < .05. 
Baseline insulin levels were only decreased in the RYGB compared with sham controls (Fig. 3C). Although 
all surgical groups exhibited an increase in insulin 15 minutes after an oral mixed-meal load compared 
with baseline, only OAGB and SADS had a glucose-stimulated insulin response greater than sham (Fig. 
3C). Using a repeated-measures analysis of variance, total GLP-1 in plasma was significantly increased 15 
minutes after an oral mixed-meal in all surgical groups compared with sham (P < .01; Fig. 3D). Moreover, 
post hoc analysis with Sidak's multiple comparison test revealed OAGB had increased total GLP-1 
compared with SG (P < .01) and SADS (P < .01) at 15 minutes postgavage. 
Surgical effect on lipid regulation 
Circulating ad libitum plasma levels of cholesterol were significantly reduced in rats undergoing OAGB, 
SG, and RYGB compared with sham (Fig. 4A). No differences were observed in circulating levels of 
nonesterified fatty acids (Fig. 4B). Plasma triglyceride levels were reduced after OAGB and SG compared 
with sham (Fig. 4C). While there were no significant reductions in plasma triglycerides in the RYGB or 
SADS groups, there was a significant reduction in liver triglycerides (Figs. 4C, 4D). Indeed, liver 
triglycerides were significantly reduced in all bariatric surgical groups compared with sham (Fig. 4D). 
Moreover, post hoc analysis revealed that OAGB (P < .01), RYGB (P < .001), and SADS (P < .05) had lower 
liver triglycerides compared with SG. 
 
Fig. 4. Surgical effect on lipid regulation. (A) Plasma cholesterol levels. **Significant difference from sham, P < .01. 
(B) Plasma free fatty acids (FFA). (C) Plasma triglycerides. *Significant difference from sham, P < .05, **P < .01. (D) 
Liver triglycerides expressed as milligram per gram of liver tissue. ***Significant difference from sham, P < .001, 
****P < .0001. 
Surgical effect on iron regulation 
Compared with sham-operated controls, total circulating iron levels were reduced in all surgery groups 
except for RYGB (Fig. 5A). Hematocrit was reduced in rats undergoing SADS, RYGB, and OAGB compared 
with sham (Fig. 5B). Moreover, post hoc analysis revealed hematocrit of OAGB was significantly reduced 
compared with SG (P > .001). Although a trend was observed for an increase in reticulocyte count in all 
groups, only SADS- and SG-operated rats had a significantly elevated reticulocyte count compared with 
sham (Fig. 5C). 
 
Fig. 5. Surgical effect on iron regulation. (A) Total circulating iron levels. *Significant difference from sham, P < .05, 
**P < .01, ***P < .001. (B) Hematocrit levels, *Significant difference from sham, P < .05, **P < .01, ****P < .0001. 
(C) Reticulocyte count. *Significant difference from sham, P < .05. 
Surgical effect on the fecal microbiome 
θYC was used to determine the ability of the surgery to procedure distinct microbiome communities. θYC 
distances were significantly large for all surgical comparisons with sham except SG versus sham 
(Wilcoxon test P < .05), pointing to distinct microbiome communities occurring within all surgeries 
except SG (Fig. 6A, Table 1). Lack of significance in the SG group may be related to the variability in 
postsurgical weight. Specifically, axis 2 of θYC significantly predicted 15-week postsurgical weight within 
the SG group (R2 = .35, F1,10 = 5.32, P < .05). In particular, 8 operational taxonomic units (OTUs) with an 
linear discriminant analysis (LDA) score >4 were identified as differently abundant across the surgical 
groups (Table 2). However, no significant differences were observed in microbiome diversity or richness 
as calculated using the inverse Simpson measure (Fig. 6B). 
 
Fig. 6. Surgical effect on the fecal microbiome. (A) There were significant differences in the microbiota of most 
surgical groups, as calculated by measuring the distance between communities (θYC). Only sleeve gastrectomy 
versus sham was found to be similar in microbiome population. (B) No significant differences were observed in 
microbiome diversity as calculated using the inverse Simpson measure. 
Table 1. Surgical effect on the fecal microbiome population 
 
OAGB SG RYGB SADS 
Sham <.001 .216 .002 .001 
OAGB 
 
<.001 .046 .029 
SG 
  
<.001 <.001 
RYGB 
   
.013 
OAGB = one-anastomosis gastric bypass; SADS = single-anastomosis duodenal switch; RYGB = Roux-en-Y gastric 
bypass; SG = sleeve gastrectomy (vertical). 
P value comparison of θYC values across surgical groups. 
 
Table 2. Surgical effect on the fecal microbiome population 
LDA P value Group Taxonomy 
4.4893 1.01E−05 RYGB Bacteria; bacteroidetes; bacteroidia; bacteroidales; rikenellaceae; 
alistipes 
4.55226 2.46E−06 SG Bacteria; firmicutes; clostridia; clostridiales; ruminococcaceae 
4.35383 2.23E−05 Sham Bacteria; firmicutes; clostridia; clostridiales; lachnospiraceae; 
clostridium_XlVa 
4.33306 4.59E−05 SADS Bacteria; firmicutes; clostridia; clostridiales; lachnospiraceae; 
clostridium_XlVa 
4.19178 1.35E−05 SADS Bacteria; firmicutes; clostridia; clostridiales; lachnospiraceae; 
clostridium_XlVa 
4.27848 6.72E−06 SADS Bacteria; bacteroidetes; bacteroidia; bacteroidales; 
porphyromonadaceae 
4.05671 2.63E−05 OAGB Bacteria; bacteroidetes; bacteroidia; bacteroidales; 
porphyromonadaceae; barnesiella 
4.26218 1.70E−06 Sham Bacteria; firmicutes; clostridia; clostridiales; lachnospiraceae; blautia 
RYGB = Roux-en-Y gastric bypass; SG = sleeve gastrectomy (vertical); SADS = single-anastomosis duodenal switch; 
OAGB = one-anastomosis gastric bypass; OTU = operational taxonomic unit; LDA = linear discriminant analysis.. 
Differently abundant OTUs across surgical groups. 
Discussion 
Echoing the observation in humans, we found that rat models of bariatric surgical procedures led to 
significant and sustained weight loss and improvements in glucose metabolism. However, as 
summarized in Fig. 7, SG, SADS, RYGB, and OAGB incorporated different surgical approaches and 
resulted in differential effects on metabolic outcomes. Using this controlled animal model, we observed 
that OAGB met or exceeded the metabolic outcomes of RYGB, including increased weight loss, lipid 
reduction, and increased glucose-stimulated insulin and total GLP-1 release. 
 
Fig. 7. Summary of surgical procedures and their major effects on metabolism. 
We found that weight loss was significantly reduced in all surgical groups, with the most robust 
reductions in fat mass occurring in the OAGB and RYGB groups. Although a combined, clinical meta-
analysis including all surgical procedures performed in this study is not available, separate clinical 
reports are available for comparison. In general, clinical and randomized controlled trials have indicated 
similar weight loss between RYGB and SG.12,13 However, some report greater fat mass loss in RYGB 
compared with SG,14 in agreement with our results. A randomized control trial found that OAGB 
produced weight loss comparative to SG,15 although OAGB was associated with better glycemic 
control.15,16 A recent report on the weight outcomes of SADS versus RYGB indicated no differences in 
weight loss or diabetes remission.17 
OAGB and SG groups had decreased cumulative food intake compared with sham over the course of the 
experiment, contributing to weight loss. Although transient reductions in food intake were observed in 
all surgical groups, RYGB and SADS did not have any cumulative reduction in food intake, suggesting that 
these groups may experience an increase in energy expenditure or a decrease in nutrient absorption to 
account for the observed weight loss. 
Notably, both OAGB and RYGB exhibit the most robust weight loss and leave the dissected stomach 
tissue in the body. Retaining the stomach tissue potentially allows gut hormones to be produced and 
pass readily into the circulation. OAGB also had the highest increases in GLP-1 levels in response to an 
oral glucose load. GLP-1 has robust actions on glucose regulation18 and higher levels are associated with 
lowered glucose and insulin levels and improved metabolic health.19 Although improvement in fasting 
blood glucose was observed only in SG rats, glucose-induced insulin secretion was dramatically 
improved in all surgical groups. 
An improved lipid profile was observed in all surgical groups, with the most profound decrease in 
plasma cholesterol and triglycerides observed in OAGB and SG, which could be attributed to the lower 
food intake also observed in these groups. Lower liver triglycerides reflect improved metabolism and 
lipid processing.20,21 Although all surgical groups experienced a significant decrease in liver triglycerides, 
the most profound decreases in liver triglycerides occurred in surgical groups where nutrients were 
rerouted from the original path (e.g., RYGB, OAGB, and SADS). These data are consistent with the clinical 
data that, in general, indicate that RYGB reduces triglycerides more profoundly than SG.22,23 Comparison 
studies examining triglyceride levels in OAGB and SADS are limited. One clinical study found that RYGB, 
OAGB, and SADS had similarly reduced triglyceride levels, consistent with the present data; however, 
there was no SG control to determine whether triglycerides were more robustly decreased in RYGB, 
OAGB, and SADS compared with SG.17 However, 2 recent studies comparing OAGB to SG found no 
significant differences in triglycerides.16,23 When comparing preclinical rodent data with human clinical 
data, it is important to point out that clinical studies use plasma triglycerides, and in the present study, 
we found that plasma triglycerides were only significantly reduced compared with sham after OAGB and 
SG. Therefore, in the rat model, liver triglycerides may be a more appropriate indicator of clinical lipid 
metabolism postsurgery. 
Iron deficiency and related anemia are common phenomena after bariatric surgery and has primarily 
been attributed to bypassing the duodenum.24,25,26,27 However, we find that except for RYGB, all surgical 
interventions reduced circulating iron levels. To maintain sufficient circulating iron levels, red blood cells 
are degraded by the macrophages to free hemoglobin-bound iron. Accordingly, hematocrit levels are 
decreased compared with sham in all bariatric surgical groups except for SG. An increased reticulocyte 
count is indicative of increased erythropoiesis at the level of the bone marrow and, combined with a 
reduced hematocrit level, is indicative of an increased erythrocyte turnover rate. Altogether, these data 
suggest that the low hematocrit levels observed in OAGB, SG, and SADS are caused by an increase of 
erythrocyte degradation to compensate for disrupted intestinal iron absorption.28 These rodent data are 
consistent with the clinical data in which iron deficiency and related anemia are common phenomena 
and more prevalent after duodenal bypass interventions than after SG. Although not directly assessed in 
the present study, these data are complementary to the nutritional malabsorption observed after 
clinical OAGB and SADS procedures.5,29 Taken together, malabsorption is an important variable to 
consider when evaluating the metabolic outcome of a bariatric surgical procedure. 
The fecal microbiome was significantly altered in OAGB, SADS, and RYGB surgical groups. These data 
point to the impact of rerouting nutrients and their effect on the microbiome independent of stomach 
tissue presence, incretins, the magnitude of weight loss, or changes in food intake. Indeed, a number of 
studies have shown a shift in the microbiota after RYGB.10,30,31 Similarly, others have shown a significant 
increase in Bacteroidetes population, which is linked with decreased fat mass and leptin levels8,31,32 after 
SG. However, in this data set, we did not observe a significant difference in the microbiome of rats after 
SG compared with sham. Part of this may be due to high weight variability in the SG rats as a regression 
analysis indicated that axis 2 of θYC significantly predicted 15-week postsurgical weight in the SG group. 
In the present study, we observe higher death rates after RYGB, OAGB, and SADS procedures compared 
with SG or sham, which is a potential limitation in our interpretations and conclusions. We suspect the 
loss to be due to the technical difficulty of performing the anastomosis technique in the relatively small 
rat model. Nevertheless, we have previously found that 6 to 7 animals per group is sufficient for robust 
metabolic analysis for animal studies of bariatric surgical procedures33 and that the retention rate from 
the present study is in line with our previous observations. 
In extrapolating our results to clinical practice, one key limitation of the present study is our surgical 
procedures for the OAGB and SADS do not exactly mirror those performed in humans. While we 
endeavored to closely recapitulate the clinical operations, we elected to standardize limb length across 
the RYGB, OAGB, and SADS produces, deviating from clinical practice. This standardization is important 
as it allows us to draw conclusions about how a specific manipulation to the gut, such as a single 
anastomosis (e.g., OAGB) and/or rerouting of nutrients in the context of a sleeve (e.g., SADS), affects 
metabolism without the added confounding variable of limb length. While limb length may be a 
contributing factor to metabolic outcomes, previous research has not found limb length to be a factor in 
weight loss obtained after RYGB.34 Therefore, while these data cannot be directly applied to humans due 
to the methodic deviation from clinical OAGB and SADS, these data increase our understanding of how 
systemic changes to the gut can alter metabolism, which has marked clinical implications. 
Conclusions 
The results from these studies reveal that OAGB, SADS, RYGB, and SG surgical procedures have 
overlapping effects on a variety of parameters, including body fat, glucose regulation, insulin secretion, 
GLP-1 secretion, iron regulation, and lipid metabolism (Fig. 7). However, there remain important 
differences among these procedures that may contribute to different clinical effects. The ability to 
perform carefully controlled studies to directly compare the effects of multiple procedures is a major 
advantage of rodent models. The present data demonstrate that OAGB meets or exceeds the metabolic 
improvements induced by RYGB. 
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